Leave Your Message
News Categories
Featured News

Bioyitech Shines at FIA 2025: Setting a New Industry Benchmark with Clinical-Grade Probiotics from Top-Tier Hospitals

2025-07-08

The highly anticipated 2025 Health Ingredients & Food Ingredients China (FiA) concluded successfully at the National Exhibition and Convention Center in Shanghai. At this industry-leading event, Bioyitech showcased its innovative probiotic health solutions and novel ingredients, focusing on metabolic health and addressing the "four highs" (hyperglycemia, hyperlipidemia, hypertension, and hyperuricemia). The clinical-grade Probiotics, developed in collaboration with top-tier hospitals, garnered significant attention from industry professionals.

Clinical-Grade Probiotics from Top-Tier Hospitals.png

Strategic Focus on Metabolic Health, Establishing a New Industry Standard

 

The probiotic market is experiencing rapid growth, driven by increased living standards and heightened health awareness. Consumers are increasingly seeking probiotic products to improve gut health and regulate bodily functions.

Clinical-Grade Probiotics from Top-Tier Hospitals 1.png

Bioyitech has proactively addressed this market demand by strategically focusing on the metabolic health sector. The company has conducted in-depth clinical research with the Second Affiliated Hospital of Zhejiang University School of Medicine and the Guangdong Provincial People's Hospital. Rigorous scientific experiments and long-term clinical observations have validated the significant efficacy of Bioyitech's probiotic products in regulating metabolism and improving the "four highs." At the exhibition, Bioyitech unveiled its pioneering Probiotic Solutions, theCompound Lactic Acid Bacteria Powder ZC-URA and Compound Lactic Acid Bacteria Powder ZC-SUGII, which are the first in the nation to receive authoritative clinical endorsements from top-tier hospitals.

 

In terms of research collaboration and innovation, Bioyitech has partnered with Dalian Polytechnic University to explore the application of microorganisms in human health. At the 2025 New Food Ingredient Technology Innovation Seminar, hosted by Food Industry Technology, Professor Yanfeng Tu from Dalian Polytechnic University presented research findings on "Treating and Preventing Chronic Diseases: How Probiotics Assist in Metabolic Disease Management." Professor Tu elaborated on the unique advantages and significant potential of probiotics in regulating human metabolism and preventing chronic diseases, providing attendees with a fresh academic perspective.

Clinical-Grade Probiotics from Top-Tier Hospitals 2.png